Which Medication Is Best? VA Genetic Tests May Have the AnswerOctober 4, 2024Conference CoverageOncologyMental HealthCardiology
Transgender Women and Prostate Cancer: It’s ComplicatedSeptember 23, 2024Prostate CancerGenitourinary CancerOncologySexual Health
A CRC Blood Test Is Here. What Does it Mean for Screening?September 20, 2024OncologyColorectal CancerColon and Rectal
Fecal Immunochemical Test Performance for CRC Screening Varies WidelySeptember 19, 2024OncologyColorectal CancerColon and Rectal
Short Interval Repeat Colonoscopy After Inadequate Bowel Preparation Is Low Among VeteransSeptember 18, 2024OncologyColon and Rectal
Implementation of a Prior Authorization Drug Review Process for Care in the Community Oncology PrescriptionsSeptember 12, 2024OncologyCancer
VA Cancer Clinical Trials as a Strategy for Increasing Accrual of Racial and Ethnic Underrepresented GroupsSeptember 12, 2024OncologyCancer
Posterior Reversible Encephalopathy Syndrome (PRES) Following Bevacizumab and Atezolizumab Therapy in Hepatocellular Carcinoma (HCC)September 12, 2024OncologyHepatocellular Carcinoma
CDK7 Inhibition in Patient-Derived Organoid Modeling of Biliary Tract CancersSeptember 12, 2024Oncology
The OCTAGON Project: A Novel VA-Based Telehealth Intervention for Oral Chemotherapy MonitoringSeptember 12, 2024Prostate CancerOncologyCancerLung Cancer
Carboplatin as a Radiosensitizing Agent in Locally Advanced Head and Neck Cancer: Friendly to an Older Veteran PopulationSeptember 12, 2024Oncology
How to Make Keeping Up With the Drugs as Easy as Keeping Up With the Kardashians: Implementing a Local Oncology Drug Review CommitteeSeptember 12, 2024OncologyCancer
PHASER Testing Initiative for Patients Newly Diagnosed With a GI MalignancySeptember 12, 2024OncologyCancerColon and Rectal
